ADIPOQ and breast cancer: A case-control study that prospectively assessed whether plasma levels of inflammatory markers such as CRP, TNF-α, IL-6, leptin, and adiponectin were associated with breast cancer risk showed no significant association between these inflammatory markers and breast cancer risk but found significant interactions between menopausal status and plasma levels.